sellNotable cluster of 5
Greenstreet Yvonne sold $1.3M of ALNY
Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC.. 5,219 shares at an average of $250.98, traded Nov 26, 2024, filed Nov 27, 2024.
Warning score
65Value
$1.3M
5,219 shares
Holdings after
78,880
-6% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001735276-24-000108, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 25, 2024 | AGrant or award Common Stock | +10,658 | $0.00 | $0 | 84,099 | Nov 27, 2024 |
| Nov 26, 2024 | SOpen-market sale Common Stock | -93 | $247.77 | $23k | 84,006 | Nov 27, 2024 |
| Nov 26, 2024 | SOpen-market sale Common Stock | -762 | $249.60 | $190k | 83,244 | Nov 27, 2024 |
| Nov 26, 2024 | SOpen-market sale Common Stock | -1,131 | $250.68 | $284k | 82,113 | Nov 27, 2024 |
| Nov 26, 2024 | SOpen-market sale Common Stock | -2,933 | $251.42 | $737k | 79,180 | Nov 27, 2024 |
| Nov 26, 2024 | SOpen-market sale Common Stock | -300 | $252.27 | $76k | 78,880 | Nov 27, 2024 |
Related signals
Other insiders at ALNYLAM PHARMACEUTICALS, INC. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 17Weak | sell10b5-1 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal CMO & EVP Dev & Med Affairs | $440k | 1,752 | |
| 37Weak | sell 510b5-1 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | $755k | 3,000 | |
| 50Moderate | sell 5 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga EVP, Chief Commercial Officer | $369k | 1,469 | |
| 53Moderate | sell 5 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. EVP, Chief Financial Officer | $422k | 1,682 | |
| 46Moderate | sell 5 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal CMO & EVP Dev & Med Affairs | $422k | 1,682 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.